Clinical Trial Update: INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by Universiteit Antwerpen is evaluating inflammation-based stratification for immune-targeted augmentation in adults with maj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Universiteit Antwerpen | Conditions: Major Depressive Disorder, Inflammation | Phase 3 | Status: RECRUITING